Grazoprevir hydrate (MK-5172 hydrate)
98%
- Product Code: 110159
CAS:
1350462-55-3
| Molecular Weight: | 784.92 g./mol | Molecular Formula: | C₃₈H₅₂N₆O₁₀S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
Grazoprevir hydrate is primarily used in the treatment of chronic hepatitis C virus (HCV) infection. It functions as a potent inhibitor of the HCV NS3/4A protease, which is essential for viral replication. This compound is often combined with other antiviral agents, such as elbasvir, to enhance its efficacy and reduce the risk of resistance. The combination therapy is particularly effective against multiple HCV genotypes, offering a broad-spectrum antiviral solution. It is administered orally, providing a convenient treatment option for patients. Grazoprevir hydrate has shown significant success in achieving sustained virologic response (SVR), which is indicative of a cure for HCV infection. Its use has revolutionized HCV treatment by offering higher cure rates, shorter treatment durations, and fewer side effects compared to older therapies.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | £864.69 |
+
-
|
Grazoprevir hydrate (MK-5172 hydrate)
Grazoprevir hydrate is primarily used in the treatment of chronic hepatitis C virus (HCV) infection. It functions as a potent inhibitor of the HCV NS3/4A protease, which is essential for viral replication. This compound is often combined with other antiviral agents, such as elbasvir, to enhance its efficacy and reduce the risk of resistance. The combination therapy is particularly effective against multiple HCV genotypes, offering a broad-spectrum antiviral solution. It is administered orally, providing a convenient treatment option for patients. Grazoprevir hydrate has shown significant success in achieving sustained virologic response (SVR), which is indicative of a cure for HCV infection. Its use has revolutionized HCV treatment by offering higher cure rates, shorter treatment durations, and fewer side effects compared to older therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :